Fineotex Chemical Ltd
Incorporated in 1979, Fineotex Chemicals Ltd is engaged in the business of manufacturing auxiliaries and specialty chemicals for textiles, construction, water treatment, fertilizer, leather, and paint industries[1]
- Market Cap ₹ 3,871 Cr.
- Current Price ₹ 33.2
- High / Low ₹ 35.8 / 19.0
- Stock P/E 42.1
- Book Value ₹ 6.48
- Dividend Yield 0.24 %
- ROCE 16.5 %
- ROE 13.3 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 20.6% CAGR over last 5 years
- Company's median sales growth is 16.3% of last 10 years
Cons
- Earnings include an other income of Rs.41.1 Cr.
- Working capital days have increased from 114 days to 164 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE Commodities BSE 1000
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65 | 68 | 75 | 90 | 113 | 129 | 129 | 250 | 296 | 419 | 439 | 397 | |
| 54 | 50 | 56 | 66 | 87 | 101 | 98 | 197 | 235 | 305 | 334 | 316 | |
| Operating Profit | 11 | 19 | 19 | 24 | 25 | 28 | 31 | 53 | 61 | 113 | 106 | 81 |
| OPM % | 17% | 27% | 25% | 26% | 22% | 22% | 24% | 21% | 21% | 27% | 24% | 20% |
| 5 | 4 | 10 | 8 | 1 | -9 | 16 | 6 | 11 | 32 | 27 | 41 | |
| Interest | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 5 | 7 | 8 |
| Profit before tax | 15 | 22 | 28 | 30 | 25 | 17 | 45 | 57 | 68 | 141 | 125 | 113 |
| Tax % | 27% | 31% | 24% | 29% | 31% | 37% | 20% | 23% | 23% | 21% | 22% | 19% |
| 11 | 15 | 21 | 21 | 17 | 11 | 36 | 44 | 52 | 111 | 97 | 92 | |
| EPS in Rs | 0.10 | 0.13 | 0.19 | 0.19 | 0.16 | 0.10 | 0.32 | 0.40 | 0.47 | 1.00 | 0.85 | 0.79 |
| Dividend Payout % | 10% | 15% | 5% | 10% | 6% | 5% | 9% | 10% | 17% | 16% | 9% | 6% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 25% |
| 3 Years: | 10% |
| TTM: | -10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 21% |
| 3 Years: | 21% |
| TTM: | -5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 32% |
| 3 Years: | 4% |
| 1 Year: | 41% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 20% |
| 3 Years: | 20% |
| Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 23 | 116 |
| Reserves | 48 | 61 | 80 | 99 | 116 | 125 | 159 | 200 | 247 | 336 | 606 | 638 |
| 2 | 3 | 1 | 5 | 2 | 3 | 3 | 2 | 7 | 5 | 0 | 0 | |
| 12 | 10 | 12 | 14 | 19 | 21 | 28 | 47 | 46 | 68 | 65 | 64 | |
| Total Liabilities | 85 | 97 | 115 | 139 | 159 | 171 | 213 | 271 | 323 | 431 | 695 | 818 |
| 11 | 12 | 20 | 22 | 28 | 33 | 52 | 67 | 81 | 90 | 123 | 130 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 7 | 0 |
| Investments | 39 | 48 | 56 | 64 | 58 | 62 | 43 | 28 | 76 | 149 | 347 | 343 |
| 36 | 37 | 39 | 54 | 73 | 76 | 115 | 176 | 165 | 193 | 219 | 345 | |
| Total Assets | 85 | 97 | 115 | 139 | 159 | 171 | 213 | 271 | 323 | 431 | 695 | 818 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8 | 9 | 11 | 9 | 3 | 22 | -1 | 13 | 66 | 69 | 58 | -73 | |
| -5 | -6 | -5 | -8 | 4 | -17 | -6 | 7 | -69 | -11 | -257 | 63 | |
| -3 | -2 | -6 | -2 | -1 | -2 | -3 | -4 | -5 | -23 | 173 | 32 | |
| Net Cash Flow | 1 | 1 | -1 | -2 | 6 | 3 | -10 | 17 | -7 | 35 | -26 | 22 |
| Free Cash Flow | 3 | 8 | 6 | 7 | -4 | 16 | -23 | -2 | 49 | 56 | 11 | -82 |
| CFO/OP | 102% | 91% | 96% | 74% | 44% | 102% | 22% | 51% | 135% | 89% | 77% | -68% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 95 | 102 | 98 | 90 | 112 | 111 | 163 | 110 | 90 | 95 | 80 | 93 |
| Inventory Days | 40 | 54 | 71 | 97 | 86 | 68 | 121 | 127 | 80 | 58 | 76 | 98 |
| Days Payable | 80 | 91 | 109 | 92 | 93 | 94 | 133 | 109 | 85 | 91 | 77 | 63 |
| Cash Conversion Cycle | 54 | 64 | 60 | 94 | 105 | 85 | 152 | 128 | 86 | 61 | 79 | 129 |
| Working Capital Days | 54 | 70 | 79 | 106 | 139 | 121 | 189 | 143 | 90 | 78 | 99 | 164 |
| ROCE % | 17% | 27% | 30% | 27% | 19% | 21% | 27% | 28% | 27% | 44% | 25% | 16% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Count Count |
|
|||||||||||
| Market Reach (Countries) Count |
||||||||||||
| Sales Volume MT |
||||||||||||
| Installed Production Capacity MTPA |
||||||||||||
| Total SKUs Count |
||||||||||||
| Number of Dealers/Distributors Count |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
2d - Fineotex released Q4 FY26 earnings call transcript; revenue rose 162% to ₹314 crore, PAT up 118% to ₹44 crore.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
18 May - Audio recording of Q4 FY2025-26 investor and analyst concall made available on website.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
16 May - Investor Presentation for the financial result of the company for the quarter and year ended March 31, 2026
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
16 May - Q4 FY26 revenue ₹313.73 crore, PAT ₹43.79 crore; new Midland facility doubles CrudeChem capacity.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 May - Newspaper Publicatio of Annual Audited Financial Statement for the quarter and year ended March 31, 2026
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT
-
Dec 2025TranscriptPPT
-
Dec 2025TranscriptPPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Nov 2024TranscriptAI SummaryPPT
-
Aug 2024Transcript PPT REC
-
Aug 2024TranscriptAI SummaryPPT
-
Jun 2024Transcript PPT
-
May 2024TranscriptAI SummaryPPT
-
Mar 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Nov 2023TranscriptAI SummaryPPT
-
Nov 2023TranscriptAI SummaryPPT
-
Nov 2023TranscriptAI SummaryPPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
Jun 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Jan 2023TranscriptAI SummaryPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptAI SummaryPPT
-
May 2022Transcript PPT
-
Apr 2022TranscriptAI SummaryPPT
-
Jan 2022Transcript PPT
-
Jan 2022TranscriptAI SummaryPPT
-
Nov 2021Transcript PPT
-
Nov 2021TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021Transcript PPT
-
Jul 2021TranscriptAI SummaryPPT
-
May 2021Transcript PPT
-
Apr 2021TranscriptAI SummaryPPT
-
Feb 2021Transcript PPT
-
Jan 2021TranscriptAI SummaryPPT
-
Jan 2021TranscriptAI SummaryPPT
-
Nov 2020TranscriptAI SummaryPPT
-
Nov 2020TranscriptAI SummaryPPT
-
Nov 2020TranscriptAI SummaryPPT
-
Sep 2020TranscriptAI SummaryPPT
-
Jul 2020TranscriptAI SummaryPPT
-
Feb 2020TranscriptAI SummaryPPT
-
Feb 2020TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018TranscriptAI SummaryPPT
-
Nov 2018TranscriptAI SummaryPPT
-
Aug 2018Transcript PPT
-
Aug 2018TranscriptAI SummaryPPT
-
Jun 2018Transcript PPT
-
Jun 2018TranscriptAI SummaryPPT
-
Jun 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Dec 2017TranscriptAI SummaryPPT
-
Dec 2017TranscriptAI SummaryPPT
-
Sep 2017TranscriptAI SummaryPPT
-
Sep 2017TranscriptAI SummaryPPT
-
May 2017TranscriptAI SummaryPPT
-
Mar 2017Transcript PPT
-
Feb 2017TranscriptAI SummaryPPT
-
Nov 2016Transcript PPT
-
Nov 2016TranscriptAI SummaryPPT
-
Aug 2016Transcript PPT
-
Aug 2016TranscriptAI SummaryPPT
-
May 2016Transcript PPT
-
Mar 2016TranscriptAI SummaryPPT
-
Mar 2016TranscriptAI SummaryPPT
-
Feb 2016TranscriptAI SummaryPPT
-
Nov 2015TranscriptAI SummaryPPT
-
Aug 2015TranscriptAI SummaryPPT
Product Offerings[1]
The company manufactures over 470 specialty chemicals and enzymes catering to textiles, garments, construction, leather, water treatment, agrochemicals, adhesives and other industries across ~70 countries. The Company is a leading manufacturer of textile specialty and performance chemicals, offering products across the pre-treatment, dyeing, printing and finishing value chain. It has also expanded into the health and hygiene segment, including detergent and handwash products.